Ligand ID: ZON Drugbank ID: DB00909(Zonisamide) Indication:For use as adjunctive treatment of partial seizures in adults with epilepsy. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | TYR A 126CYH A 145TYR A 118TYR A 161 | 1.78A | 15.22 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | TYR A 126CYH A 145TYR A 118TYR A 161 | 1.77A | 19.54 | NoneELL D 3 (-1.7A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | TYR A 126CYH A 145TYR A 118TYR A 161 | 1.76A | 19.54 | NoneELL D 3 (-1.8A)DMS A 403 ( 4.1A)None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | TYR D 126CYH D 145TYR D 118TYR D 161 | 1.77A | 20.00 | None3WL D 401 (-3.3A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | TYR C 126CYH C 145TYR C 118TYR C 161 | 1.77A | 20.00 | None3WL C 401 (-3.2A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | TYR B 126CYH B 145TYR B 118TYR B 161 | 1.74A | 20.00 | None3WL B 401 (-3.2A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | TYR B 113LEU B 160TYR B 88TYR B 112 | 1.44A | 13.09 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 786GLN A 698TYR A 619PHE A 782 | 1.61A | 18.55 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | TYR A 286LEU A 316PHE A 317TYR A 238 | 1.76A | 18.55 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 8 | TYR A 112LEU A 159TYR A 87TYR A 111 | 1.47A | 13.50 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 8 | TYR B 112LEU B 159TYR B 87TYR B 111 | 1.48A | 13.50 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6w37 | PROTEIN 7A (SARS-CoV-2) | 4 / 8 | TYR A 60LEU A 41PHE A 39TYR A 25 | 1.35A | 8.95 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | LEU C 513PHE C 338TYR C 365TYR C 369 | 1.79A | 15.87 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | LEU A 234GLN A 237TYR A 213PHE A 216 | 1.80A | 19.39 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | TYR A 71LEU A 80TYR A 56TYR A 154 | 1.79A | 19.39 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | TYR A 112LEU A 159TYR A 87TYR A 111 | 1.37A | 13.70 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | TYR D 112LEU D 159TYR D 87TYR D 111 | 1.47A | 13.70 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | TYR C 112LEU C 159TYR C 87TYR C 111 | 1.48A | 13.70 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | TYR B 112LEU B 159TYR B 87TYR B 111 | 1.43A | 13.70 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | TYR A 126CYH A 145TYR A 118TYR A 161 | 1.75A | 20.00 | NoneU5G A 401 (-1.8A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6wxd | NSP9 (SARS-CoV-2) | 4 / 8 | TYR B 31LEU A 4CYH B 73PHE B 75 | 1.27A | 13.16 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6xez | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 786GLN A 698TYR A 619PHE A 782 | 1.49A | 18.41 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | LEU A 390PHE A 515TYR A 365TYR A 369 | 1.35A | 17.35 | DMS A 905 (-4.9A)NoneNoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | LEU A 390PHE A 392TYR A 365TYR A 369 | 1.58A | 17.35 | DMS A 905 (-4.9A)NoneNoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | TYR A 126CYH A 145TYR A 118TYR A 161 | 1.75A | 20.00 | NoneP6N A 502 (-1.5A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | TYR A 126CYH A 145TYR A 118TYR A 161 | 1.75A | 20.00 | NonePK8 A 401 ( 1.4A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6zsl | SARS-COV-2 HELICASENSP13 (SARS-CoV-2) | 4 / 8 | TYR A 476LEU A 573CYH A 574GLN A 492 | 1.44A | 22.68 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6zsl | SARS-COV-2 HELICASENSP13 (SARS-CoV-2) | 4 / 8 | LEU B 461CYH B 441GLN B 404TYR B 457 | 1.45A | 22.68 | NoneNonePO4 B 705 (-2.9A)None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 6zsl | SARS-COV-2 HELICASENSP13 (SARS-CoV-2) | 4 / 8 | LEU A 461CYH A 441GLN A 404TYR A 457 | 1.48A | 22.68 | NoneNonePO4 A 705 (-2.8A)None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | TYR A 126CYH A 145TYR A 118TYR A 161 | 1.77A | 20.00 | NonePJE C 5 (-1.7A)NoneNone | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | TYR A 921TYR A 884PHE A 881TYR A 925 | 1.57A | 18.55 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | TYR A 286LEU A 316PHE A 317TYR A 238 | 1.80A | 18.55 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 786GLN A 698TYR A 619PHE A 782 | 1.47A | 18.55 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 786GLN A 698TYR A 619PHE A 782 | 1.43A | 18.85 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | TYR A 286LEU A 316PHE A 317TYR A 238 | 1.77A | 18.85 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | TYR A 163LEU A 142PHE A 134TYR A 175 | 1.77A | 18.85 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 240GLN A 468TYR A 732TYR A 788 | 1.58A | 18.85 | None | ||
![]() | 3PO7_A_ZONA601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | LEU A 786GLN A 698TYR A 619PHE A 782 | 1.42A | 18.85 | None |